tiprankstipranks
Voyageur Pharmaceuticals (VYYRF)
OTHER OTC:VYYRF

Voyageur Pharmaceuticals (VYYRF) Financial Statements

2 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -5.26; Voyageur Pharmaceuticals is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -273.60KC$ -130.69KC$ -621.49KC$ -373.69K-
EBITDAC$ -273.05KC$ -130.69KC$ -620.40KC$ -373.15K-
Net Income Common StockholdersC$ -273.60KC$ -130.69KC$ -621.49KC$ -373.69K-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 2.08KC$ 1.88KC$ 124.10KC$ 651.93KC$ 31.56K
Total AssetsC$ 2.16MC$ 2.17MC$ 2.25MC$ 2.77MC$ 2.10M
Total DebtC$ 40.00KC$ 25.52KC$ 0.00C$ 25.52KC$ 25.52K
Net DebtC$ 37.91KC$ 23.64KC$ -124.10KC$ -626.41KC$ -6.04K
Total LiabilitiesC$ 727.88KC$ 467.67KC$ 438.88KC$ 534.02KC$ 630.83K
Stockholders EquityC$ 1.44MC$ 1.71MC$ 1.81MC$ 2.24MC$ 1.46M
Cash Flow-
Free Cash Flow-C$ 390.05KC$ -1.04MC$ -512.27K-
Operating Cash Flow-C$ 402.87KC$ -953.33KC$ -470.35K-
Investing Cash Flow-C$ -12.82KC$ -86.77KC$ -41.92K-
Financing Cash Flow-C$ -1.13MC$ 1.13MC$ 1.13M-
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Voyageur Pharmaceuticals Debt to Assets

Voyageur Pharmaceuticals Cash Flow

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis